Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Statements of Changes in Stockholders' Equity (Unaudited)

v3.19.3.a.u2
Condensed Consolidated Statements of Changes in Stockholders' Equity (Unaudited) - USD ($)
$ in Thousands
Series C Preferred Stock
Common Stock
Additional Paid-In Capital
Accumulated Deficit
Accumulated Other Comprehensive Loss
Total
Beginning balance, shares at Mar. 31, 2018 0 685,747        
Beginning balance, value at Mar. 31, 2018 $ 0 $ 1 $ 176,740 $ (15,740) $ (3,975) $ 15,326
Issuance of common stock new, shares   29,710        
Issuance of common stock new, value     957     957
Issuance of common stock and warrants, shares   507,156        
Issuance of common stock and warrants, value   $ 1 3,880     3,881
Issuance of Series C convertible perferred stock, shares 10          
Issuance of Series C convertible perferred stock, value     861     861
Conversion of Series C convertible preferred stock into common stock, shares (8) 90,000        
Issuance of common stock for service fees, shares   2,736        
Issuance of common stock for service fees, value     59     59
Stock based compensation related to common stock restricted stock grants, shares   2,353        
Stock based compensation related to common stock restricted stock grants, value     95     95
Stock based compensation, net of forfeitures     1,180     1,180
Foreign currency translation adjustment         (443) (443)
Net income (loss)       (8,576)   (8,576)
Ending balance, shares at Dec. 31, 2018 2 1,317,702        
Ending balance, value at Dec. 31, 2018 $ 0 $ 2 183,772 (166,016) (4,418) 13,340
Beginning balance, shares at Sep. 30, 2018 0 719,957        
Beginning balance, value at Sep. 30, 2018 $ 0 $ 1 178,629 (163,718) (4,127) 10,785
Issuance of common stock and warrants, shares   507,156        
Issuance of common stock and warrants, value   $ 1 3,880     3,881
Issuance of Series C convertible perferred stock, shares 10          
Issuance of Series C convertible perferred stock, value     861     861
Conversion of Series C convertible preferred stock into common stock, shares (8) 90,000        
Stock based compensation related to common stock restricted stock grants, shares   589        
Stock based compensation related to common stock restricted stock grants, value     34     34
Stock based compensation, net of forfeitures     368     368
Foreign currency translation adjustment         (291) (291)
Net income (loss)       (2,298)   (2,298)
Ending balance, shares at Dec. 31, 2018 2 1,317,702        
Ending balance, value at Dec. 31, 2018 $ 0 $ 2 183,772 (166,016) (4,418) 13,340
Beginning balance, shares at Mar. 31, 2019 2 1,316,335        
Beginning balance, value at Mar. 31, 2019 $ 0 $ 2 184,074 (169,238) (4,349) 10,489
Issuance of common stock new, shares   446,577        
Issuance of common stock new, value     1,376     1,376
Reclassification of stock liability to equity, shares   12,556        
Reclassification of stock liability to equity, value     270     270
Stock based compensation related to common stock restricted stock grants, shares   2,015        
Stock based compensation related to common stock restricted stock grants, value     35     35
Stock based compensation, net of forfeitures     502     502
Foreign currency translation adjustment         168 168
Net income (loss)       (1,572)   (1,572)
Ending balance, shares at Dec. 31, 2019 2 1,777,483        
Ending balance, value at Dec. 31, 2019 $ 0 $ 2 186,257 (170,869) (4,181) 11,209
Beginning balance, shares at Sep. 30, 2019 2 1,318,004        
Beginning balance, value at Sep. 30, 2019 $ 0 $ 2 184,499 (169,785) (4,445) 10,271
Issuance of common stock new, shares   446,577        
Issuance of common stock new, value     1,376     1,376
Reclassification of stock liability to equity, shares   12,556        
Reclassification of stock liability to equity, value     270     270
Stock based compensation related to common stock restricted stock grants, shares   346        
Stock based compensation related to common stock restricted stock grants, value     6     6
Stock based compensation, net of forfeitures     106     106
Foreign currency translation adjustment         264 264
Net income (loss)       (1,084)   (1,084)
Ending balance, shares at Dec. 31, 2019 2 1,777,483        
Ending balance, value at Dec. 31, 2019 $ 0 $ 2 $ 186,257 $ (170,869) $ (4,181) $ 11,209